Table:
begin	end	state
1	234	cytoplasmic
235	262	transmembrane
263	289	non-cytoplasmic
290	310	transmembrane
311	321	cytoplasmic
322	340	transmembrane
341	373	non-cytoplasmic
374	391	transmembrane
392	419	cytoplasmic
420	441	transmembrane
442	456	non-cytoplasmic
457	482	transmembrane
483	488	cytoplasmic
489	507	transmembrane
508	524	non-cytoplasmic

Input:
>WP_086509603.1 NCBI__GCF_002151265.1:WP_086509603.1
MLGLSMTTPAAAQDAAPADDVAAMTLLEALDVDSFPAKGRAIEAIVHSDDPRARDWLQAL
LDGRLQRAGDGRFVVVLDNTGRDWPVQDALSGEPLGQMSRRELDRIGINNALRNQLRSAI
AVVDLYAADVGLRRASAERLLGEVDGDLAGPLVEVIEEEPDARVRERLVQALAIYRLEQG
ELEAIDDLQGSLHPRVRVALNRAANGDDPIVADAAREALNGIEQMLKLNRAAETLYFGLS
LGSVLVLAAIGLAITFGVMGVINMAHGELIMLGAYTTWAMQQLLPGQPGLALILAIPAGF
LVAALAGIAIERGVIQFLKGRPLETLLATFGISLILQQLVRTGISPLNRTVITPEWMSGS
IAVNDALSLTLNRMYVLGFALVVFAVLMLIMRRTRLGLEVRAVTQNRAMARSMGIRATRV
DIMTFALGSGVAGLAGVALSQLTNVGPNLGQNYIIDSFMVVVFGGVGNLWGTLVAGLSLG
VINQVLEPWAGAVMAKIIVLVFIILFIQKRPRGLFPQKGRAAEG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server